LSE:TSTL (Tristel Plc)

About TSTL

Tristel PLC is a player in the healthcare platform. The company is a manufacturer of infection prevention and contamination control products. Its core product candidate is a chlorine dioxide formulation. Its operating segments include Hospital medical device decontamination and Hospital environmental surface disinfection. It caters to three market avenues: The Human Healthcare market, The Contamination Control market, and the Animal Healthcare market. The Human Healthcare division deals with hospital infection prevention and accounts for most of the company's revenues.
  • Tristel Plc (LSE: TSTL) Latest News

    Investing Articles

    2 small-cap stocks growing at ASOS-like speed

    Edward Sheldon looks at two small-caps growing at a phenomenal pace and making their shareholders wealthy in the process.

    Read more »

    Investing Articles

    Why I’d buy Tristel plc and avoid Genus plc after HY results

    Half-year results reveal two different stories with Tristel plc (LON: TSTL) and Genus plc (LON: GNS)

    Read more »

    Investing Articles

    Can this small-cap healthcare stock continue to beat big-cap rivals?

    Roland Head looks at the latest results from a fast-growing healthcare business with strong overseas growth potential.

    Read more »

    Investing Articles

    More Top Stocks For March: Next plc, Petrofac Limited & Tristel plc

    Our analysts choose their top stock picks for the coming month: Next plc (LON:NXT), Petrofac Limited (LON:PFC) & Tristel plc…

    Read more »

    Investing Articles

    Why I’ve Shunned GlaxoSmithKline plc & AstraZeneca plc But Bought Bioventix plc & Tristel plc

    Why this Fool prefers Tristel plc (LON: TSTL) and Bioventix plc (LON: BVXP) over sector heavyweights GlaxoSmithKline plc (LON: GSK)…

    Read more »

    Investing Articles

    3 AIM Stocks For The Next 20 Years: ASOS plc, Tristel plc & OMG plc

    ASOS plc (LON:ASC), Tristel plc (LON:TSTL) & OMG plc (LON:OMG): here's to the next 20 years of the FTSE AIM…

    Read more »